NASDAQ:ATRA | Cash Flow Statement | Atara Biotherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2013-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$4.83M
2026-03-31-$4.15M-$3.07M$0.00$2.95M
2025-12-31-$3.41M-$5.7M$0.00$8.44M-$3,000.00
2025-09-30-$4.3M
2025-06-30$2.39M
2025-03-31$38.01M-$28.14M$0.00$17.2M-$250,000.00
2024-12-31-$12.69M-$24.47M$90,000.00$3.38M-$328,000.00
2024-09-30-$21.91M
2024-06-30-$19.05M
2024-03-31-$31.75M-$29.61M$127,000.00$14.72M$24.14M
2023-12-31-$60.45M-$50.41M$44,000.00$9.94M$1.51M
2023-09-30-$69.8M
2023-06-30-$71.11M
2023-03-31-$74.77M-$38.43M$399,000.00-$6.01M$235,000.00
2022-12-31-$74.57M-$56.88M$37,000.00$51.22M$32.29M
2022-09-30-$84.09M
2022-06-30$18.47M
2022-03-31-$88.11M-$84.53M$2.61M$60.22M$19.85M
2021-12-31-$93.35M-$34.27M$2.47M-$24.32M$51.47M
2021-09-30-$84.66M
2021-06-30-$83.79M
2021-03-31-$78.34M-$65.7M$2.2M$13.5M$2.89M
2020-12-31-$81.31M-$4.12M$601,000.00-$36.89M$178.8M
2020-09-30-$74.35M
2020-06-30-$77.46M
2020-03-31-$73.51M-$67.04M$1.33M$38.97M$23.96M
2019-12-31-$78.5M-$58.69M$2.71M$1.13M$37.45M
2019-09-30-$71.9M
2019-06-30-$74.33M
2019-03-31-$66.26M-$70.2M$796,000.00$67.6M-$1.93M
2018-12-31-$80.01M-$57.42M$4.17M$46.07M$6.02M
2018-09-30-$58.36M
2018-06-30-$50.88M
2018-03-31-$41.44M-$34.82M$19.81M-$249.92M$296.01M
2017-12-31-$35.31M-$24.94M$9.7M$42.97M$698,000.00
2017-09-30-$31.1M
2017-06-30-$27.43M
2017-03-31-$25.65M-$22.03M$1.21M
2016-12-31-$18.24M-$21.16M$995,000.00
2016-09-30-$25.37M
2016-06-30-$18.88M
2016-03-31-$16.56M-$12.49M$891,000.00
2015-12-31-$21.25M-$11.39M$271,000.00
2015-09-30-$11.87M
2015-06-30-$14.95M
2015-03-31-$9.16M-$6.62M$5,000.00
2014-12-31-$10.53M-$4.96M$36,000.00
2014-09-30-$5.92M
2014-06-30-$4.51M
2014-03-31-$7.05M-$2.92M$1,000.00
2013-12-31-$3.56M-$2.49M$0.00
2013-09-30-$2.54M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$32.69M-$50.94M$0.00$18.15M$16.1M
2024-12-31-$85.4M-$68.72M$246,000.00$8.62M$59.28M
2023-12-31-$276.13M-$192.98M$1.22M$123.87M$2.01M
2022-12-31-$228.3M-$270.43M$4.19M$202.96M$53.08M
2021-12-31-$340.14M-$220.52M$10.58M$22.26M$103.94M
2020-12-31-$306.62M-$180.76M$4.51M-$120.73M$427.57M
2019-12-31-$290.98M-$235.63M$5.73M$60.46M$188.79M
2018-12-31-$230.7M-$179.77M$35.93M-$196.29M$357.54M
2017-12-31-$119.49M-$87.5M$20.23M$99.91M$20.05M
2016-12-31-$79.05M-$60.03M$3.02M$83.74M$506,000.00
2015-12-31-$57.22M-$37.16M$290,000.00
2014-12-31-$28.01M-$16.63M$46,000.00
2013-12-31-$8.77M-$5.97M$3,000.00